The Clinical Safety of Alcoholic Extract Sahastara Remedy of Extract Capsule in Healthy Volunteers
- Conditions
- Osteoarthritis
- Interventions
- Drug: Sahastara remedy alcoholic extract
- Registration Number
- NCT02568059
- Lead Sponsor
- Thammasat University
- Brief Summary
The clinical safety of Sahastara remedy alcoholic extract in healthy volunteers. Investigators will investigate safety of 100 and 200 mg of Sahastara remedy extract capsule in healthy volunteers. This is Clinical trial Phase I.
- Detailed Description
The sahastara remedy (SHT) is a Thai traditional medicine that is use to relieve pain of musculoskeletal problem. There is study shown that SHT extract was not found acute and chronic toxicity in rat. However, there is no study regarding safety in human. Thus, this study is a clinical trial Phase I that investigate clinical safety of SHT alcoholic extract in healthy volunteers. The clinical safety will monitor for 28 days in continuously use of 100 and 200 mg SHT extraction 3 time a day and after stop intervention for 14 days.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 25
- No pregnancy
- No Serious Medical Condition evaluated by Physical Examination and Laboratory results in 1 month before study
- No Supplementary food and/or Vitamin during the study
- Able to follow suggestion during the study
- Uncontrolled Hypertension (BP>140/90 mm.Hg.)
- BMI > 30
- Have serious medical condition including Severe peptic ulcer, congestive heart disease, Liver and Renal dysfunction.
- On during use medicine including Rifampicin, Phenytoin, Propranolol, Theophylline
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 200 mg SHT extract Sahastara remedy alcoholic extract The Sahastara remedy alcoholic extract capsule dose 200 mg. 100 mg SHT extract Sahastara remedy alcoholic extract The Sahastara remedy alcoholic extract capsule dose 100 mg.
- Primary Outcome Measures
Name Time Method Clinical safety evaluated by History taking, Patient diary note, Physical Examination and Laboratory test including Complete Blood Count (CBC), Renal functions, Liver functions, Lipid profile, Fasting Blood Sugar (FBS), and Urinary analysis 14 days after stop intervention Clinical safety was evaluated changing from baseline,14 days and 28 days while using intervention by History taking, Patient diary note, Physical Examination and Laboratory test including Complete Blood Count (CBC), Renal functions, Liver functions, Lipid profile, Fasting Blood Sugar (FBS), and Urinary analysis
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Faculty of Medicine, Thammasat University
🇹ðŸ‡Klongnueng, Pathumthani, Thailand